Exelixis
EXEL
#1760
Rank
โ‚ฌ10.04 B
Marketcap
37,32ย โ‚ฌ
Share price
-0.41%
Change (1 day)
6.76%
Change (1 year)
Exelixis, Inc. is an American genomics-based drug discovery company and the producer of Cometriq, a treatment for medullary thyroid cancer.

We have found no stock splits for this company